Literature DB >> 17763937

Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.

Moon-Soo Lee1, Jae-Won Yang, Young-Hoon Ko, Changsu Han, Seung-Hyun Kim, Min-Soo Lee, Sook-Haeng Joe, In-Kwa Jung.   

Abstract

We evaluated plasma levels of DHEA-S and cortisol before and after treating ADHD patients with one of two medications: methylphenidate (n = 12) or bupropion (n = 10). Boys with ADHD (combined type) were evaluated with the Korean ADHD rating scale (K-ARS) and the computerized ADHD diagnostic system (ADS). All assessments were measured at baseline and repeated after 12 weeks. There were significant clinical improvements in both treatment groups as measured by K-ARS and ADS. DHEA-S levels increased from baseline to endpoint, but cortisol levels did not change significantly. This study suggests that both methylphenidate and bupropion increase plasma levels of DHEA-S in boys with ADHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763937     DOI: 10.1007/s10578-007-0081-6

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  22 in total

Review 1.  Treatment of attention-deficit-hyperactivity disorder.

Authors:  J Elia; P J Ambrosini; J L Rapoport
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

Review 2.  ADHD is best understood as a cultural construct.

Authors:  Sami Timimi; Eric Taylor
Journal:  Br J Psychiatry       Date:  2004-01       Impact factor: 9.319

3.  Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor.

Authors:  S Demirgören; M D Majewska; C E Spivak; E D London
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

4.  Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate.

Authors:  R S Rosenfeld; L Hellman; T F Gallagher
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

Review 5.  Methylphenidate: its pharmacology and uses.

Authors:  T D Challman; J J Lipsky
Journal:  Mayo Clin Proc       Date:  2000-07       Impact factor: 7.616

Review 6.  Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.

Authors:  Amy F T Arnsten
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

7.  Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.

Authors:  Rael D Strous; Rachel Maayan; Raya Lapidus; Rafael Stryjer; Michal Lustig; Moshe Kotler; Abraham Weizman
Journal:  Arch Gen Psychiatry       Date:  2003-02

8.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.

Authors:  R R Gainetdinov; W C Wetsel; S R Jones; E D Levin; M Jaber; M G Caron
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

9.  Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.

Authors:  R Bergeron; C de Montigny; G Debonnel
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

10.  NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder.

Authors:  Molupe Lehohla; Lauriston Kellaway; Vivienne Ann Russell
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

View more
  7 in total

1.  Genetic and Environmental Contributions to Covariation Between DHEA and Testosterone in Adolescent Twins.

Authors:  Carol A Van Hulle; Mollie N Moore; Elizabeth A Shirtcliff; Kathryn Lemery-Chalfant; H Hill Goldsmith
Journal:  Behav Genet       Date:  2015-01-31       Impact factor: 2.805

2.  Moderate versus severe early life stress: associations with stress reactivity and regulation in 10-12-year-old children.

Authors:  Megan R Gunnar; Kristin Frenn; Sandi S Wewerka; Mark J Van Ryzin
Journal:  Psychoneuroendocrinology       Date:  2008-10-02       Impact factor: 4.905

3.  Dysregulation of the cortisol diurnal rhythm following prenatal alcohol exposure and early life adversity.

Authors:  Kaitlyn McLachlan; Carmen Rasmussen; Tim F Oberlander; Christine Loock; Jacqueline Pei; Gail Andrew; James Reynolds; Joanne Weinberg
Journal:  Alcohol       Date:  2016-04-01       Impact factor: 2.405

4.  Does Methylphenidate Reduce Testosterone Levels in Humans? A Prospective Study in Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Liang-Jen Wang; Miao-Chun Chou; Wen-Jiun Chou; Min-Jing Lee; Pao-Yen Lin; Sheng-Yu Lee; Yi-Hsuan Lee
Journal:  Int J Neuropsychopharmacol       Date:  2017-03-01       Impact factor: 5.176

5.  Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation.

Authors:  Liang-Jen Wang; Wen-Ching Chan; Miao-Chun Chou; Wen-Jiun Chou; Min-Jing Lee; Sheng-Yu Lee; Pao-Yen Lin; Yi-Hsin Yang; Cheng-Fang Yen
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

6.  Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder.

Authors:  Alessandra Carta; Isabella Vainieri; Anna-Sophie Rommel; Alessandro Zuddas; Jonna Kuntsi; Stefano Sotgiu; Nicoletta Adamo
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

Review 7.  Transgenic mouse models for ADHD.

Authors:  Damiana Leo; Raul R Gainetdinov
Journal:  Cell Tissue Res       Date:  2013-05-17       Impact factor: 5.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.